首页 > 最新文献

British journal of hospital medicine最新文献

英文 中文
Construction of a Competency Evaluation Indicator System for Specialist Nurses in Liver Transplantation: A Delphi Study. 构建肝移植专科护士能力评价指标体系:德尔菲研究。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 Epub Date: 2024-10-14 DOI: 10.12968/hmed.2024.0374
Dan Gao, Lili Ma, Beihua Xi, Yanling Wang, Yi Bao

Aims/background: Liver transplantation specialist nurses provide comprehensive and safe care for liver transplant patients, which requires them to have a wide range of competencies. However, at present, there is no comprehensive understanding of the competency of liver transplantation specialist nurses in China, and there is a lack of comprehensive evaluation indicators. The purpose of this study was to construct a competency evaluation indicator system for specialist nurses in liver transplantation.

Methods: Utilizing the "Iceberg model" of competency, the indicator system for evaluating the competency of liver transplant specialist nurses was developed through literature review, semi-structured interviews, and two rounds of Delphi expert consultation.

Results: Twenty nursing and medical experts in liver transplantation were consulted over two rounds. The effective response rates for the expert consultation questionnaires were 90.91% and 100.00% for the first and second rounds, respectively. The coefficient of expert judgment was 0.920, the coefficient of familiarity was 0.880, and the authority coefficient was 0.900. The value range of the coefficient of variation in the second round was 0.00-0.16, both <0.25, indicating that the degree of coordination of expert opinions was high. The final competency evaluation index system for liver transplant specialist nurses encompassed 6 primary indicators, 17 secondary indicators, and 59 tertiary indicators, including professional knowledge, professional skills, social role, self-concept, personality quality, and motivation.

Conclusion: The developed competency evaluation indicator system for liver transplant specialist nurses possesses scientific validity and reliability, offering a reference for the training and assessment of liver transplant specialist nurses.

目的/背景:肝移植专科护士为肝移植患者提供全面、安全的护理服务,需要具备多方面的能力。然而,目前我国对肝移植专科护士的能力尚无全面的了解,缺乏综合评价指标。本研究旨在构建肝移植专科护士能力评价指标体系:方法:利用能力 "冰山模型",通过文献回顾、半结构式访谈和两轮德尔菲专家咨询,建立肝移植专科护士能力评价指标体系:结果:20 位肝移植护理和医学专家接受了两轮咨询。第一轮和第二轮专家咨询问卷的有效回收率分别为 90.91% 和 100.00%。专家判断系数为 0.920,熟悉系数为 0.880,权威系数为 0.900。第二轮变异系数的取值范围为 0.00-0.16,均为结论:所建立的肝移植专科护士能力评价指标体系具有科学性和可靠性,可为肝移植专科护士的培训和考核提供参考。
{"title":"Construction of a Competency Evaluation Indicator System for Specialist Nurses in Liver Transplantation: A Delphi Study.","authors":"Dan Gao, Lili Ma, Beihua Xi, Yanling Wang, Yi Bao","doi":"10.12968/hmed.2024.0374","DOIUrl":"https://doi.org/10.12968/hmed.2024.0374","url":null,"abstract":"<p><strong>Aims/background: </strong>Liver transplantation specialist nurses provide comprehensive and safe care for liver transplant patients, which requires them to have a wide range of competencies. However, at present, there is no comprehensive understanding of the competency of liver transplantation specialist nurses in China, and there is a lack of comprehensive evaluation indicators. The purpose of this study was to construct a competency evaluation indicator system for specialist nurses in liver transplantation.</p><p><strong>Methods: </strong>Utilizing the \"Iceberg model\" of competency, the indicator system for evaluating the competency of liver transplant specialist nurses was developed through literature review, semi-structured interviews, and two rounds of Delphi expert consultation.</p><p><strong>Results: </strong>Twenty nursing and medical experts in liver transplantation were consulted over two rounds. The effective response rates for the expert consultation questionnaires were 90.91% and 100.00% for the first and second rounds, respectively. The coefficient of expert judgment was 0.920, the coefficient of familiarity was 0.880, and the authority coefficient was 0.900. The value range of the coefficient of variation in the second round was 0.00-0.16, both <0.25, indicating that the degree of coordination of expert opinions was high. The final competency evaluation index system for liver transplant specialist nurses encompassed 6 primary indicators, 17 secondary indicators, and 59 tertiary indicators, including professional knowledge, professional skills, social role, self-concept, personality quality, and motivation.</p><p><strong>Conclusion: </strong>The developed competency evaluation indicator system for liver transplant specialist nurses possesses scientific validity and reliability, offering a reference for the training and assessment of liver transplant specialist nurses.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"85 10","pages":"1-17"},"PeriodicalIF":1.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identifying Prostatic Utricle Translucent Membrane in Hematospermia Patients Using a Novel Nomogram. 利用新颖的提名图识别血精症患者的前列腺尿道透明膜
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 Epub Date: 2024-10-29 DOI: 10.12968/hmed.2024.0358
Lang Wang, Zhen Wang, Mingmin Shao, Zhenzhen Jia, Zhiwen Huang, Mingming Lu, Junfeng Jing, Yanbin Zhang

Aims/Background Hematospermia, characterized by blood in the ejaculate, is a common and distressing condition in urology. Identifying the underlying causes, including translucent membranes in the prostatic utricle, is crucial for effective management. Despite advancements in diagnostic techniques, reliable predictive tools are needed to enhance preoperative planning and patient outcomes. This study aimed to develop a novel nomogram to predict the presence of translucent membranes in the prostatic utricle of hematospermia patients. Methods In total, 284 patients were selected from The Second People's Hospital of Hefei database based on inclusion and exclusion criteria. The cohort was divided into a training set (198 patients) and a validation set (86 patients). To identify risk factors associated with the prostatic utricle translucent membrane, multivariable logistic regression analysis was employed. The identified risk factors were then used to construct a predictive nomogram model. The performance of the nomogram was evaluated using several statistical tools: receiver operating characteristic (ROC) curves to assess discriminative ability, calibration curves to evaluate prediction accuracy, and decision curve analysis (DCA) to determine clinical utility. Results The findings revealed that age, duration of disease, history of seminal vesiculitis, and seminal vesicle dimensions (width, length, and thickness) were independent risk factors for the presence of a prostatic utricle translucent membrane in patients with hematospermia. Using these variables, a nomogram was developed. The nomogram demonstrated strong predictive capability, as evidenced by its performance in ROC and calibration curve analyses. Furthermore, the DCA indicated that the nomogram offered significant clinical net benefits in predicting the presence of a translucent membrane. Conclusion Clinical use of the developed nomogram can assist clinicians in identifying patients with hematospermia who have translucent membrane in the prostatic utricle and in developing individualized treatment.

目的/背景 以射精带血为特征的血精症是泌尿外科常见的一种令人痛苦的疾病。确定其根本原因(包括前列腺管内的半透明膜)对于有效治疗至关重要。尽管诊断技术不断进步,但仍需要可靠的预测工具来改进术前规划和患者预后。本研究旨在开发一种新型提名图,用于预测血精症患者前列腺管内是否存在半透明膜。方法 根据纳入和排除标准,从合肥市第二人民医院数据库中选出 284 名患者。结果分为训练集(198 例)和验证集(86 例)。为了确定与前列腺胞宫透亮膜相关的风险因素,采用了多变量逻辑回归分析。然后利用确定的风险因素构建了一个预测提名图模型。使用几种统计工具对提名图的性能进行了评估:接收器操作特征曲线(ROC)用于评估鉴别能力,校准曲线用于评估预测准确性,决策曲线分析(DCA)用于确定临床实用性。结果 研究结果显示,年龄、病程、精囊炎病史和精囊尺寸(宽度、长度和厚度)是血精症患者出现前列腺胞宫透亮膜的独立风险因素。利用这些变量开发了一个提名图。该提名图在 ROC 和校准曲线分析中的表现证明它具有很强的预测能力。此外,DCA 显示,提名图在预测是否存在半透明膜方面具有显著的临床净效益。结论 临床使用所开发的提名图可以帮助临床医生识别前列腺管内有半透明膜的血精症患者,并制定个性化治疗方案。
{"title":"Identifying Prostatic Utricle Translucent Membrane in Hematospermia Patients Using a Novel Nomogram.","authors":"Lang Wang, Zhen Wang, Mingmin Shao, Zhenzhen Jia, Zhiwen Huang, Mingming Lu, Junfeng Jing, Yanbin Zhang","doi":"10.12968/hmed.2024.0358","DOIUrl":"https://doi.org/10.12968/hmed.2024.0358","url":null,"abstract":"<p><p><b>Aims/Background</b> Hematospermia, characterized by blood in the ejaculate, is a common and distressing condition in urology. Identifying the underlying causes, including translucent membranes in the prostatic utricle, is crucial for effective management. Despite advancements in diagnostic techniques, reliable predictive tools are needed to enhance preoperative planning and patient outcomes. This study aimed to develop a novel nomogram to predict the presence of translucent membranes in the prostatic utricle of hematospermia patients. <b>Methods</b> In total, 284 patients were selected from The Second People's Hospital of Hefei database based on inclusion and exclusion criteria. The cohort was divided into a training set (198 patients) and a validation set (86 patients). To identify risk factors associated with the prostatic utricle translucent membrane, multivariable logistic regression analysis was employed. The identified risk factors were then used to construct a predictive nomogram model. The performance of the nomogram was evaluated using several statistical tools: receiver operating characteristic (ROC) curves to assess discriminative ability, calibration curves to evaluate prediction accuracy, and decision curve analysis (DCA) to determine clinical utility. <b>Results</b> The findings revealed that age, duration of disease, history of seminal vesiculitis, and seminal vesicle dimensions (width, length, and thickness) were independent risk factors for the presence of a prostatic utricle translucent membrane in patients with hematospermia. Using these variables, a nomogram was developed. The nomogram demonstrated strong predictive capability, as evidenced by its performance in ROC and calibration curve analyses. Furthermore, the DCA indicated that the nomogram offered significant clinical net benefits in predicting the presence of a translucent membrane. <b>Conclusion</b> Clinical use of the developed nomogram can assist clinicians in identifying patients with hematospermia who have translucent membrane in the prostatic utricle and in developing individualized treatment.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"85 10","pages":"1-13"},"PeriodicalIF":1.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TB or Not TB, That is the Question? 结核还是不结核,这是一个问题?
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 Epub Date: 2024-10-27 DOI: 10.12968/hmed.2024.0180
Ellen McAuliffe, Bryan Renton

A 26-year-old female presented with a 3-month history of dry cough, unintentional weight loss, night sweats and fatigue. Her background history was significant for ulcerative colitis, managed with Adalimumab for almost 2 years. Clinical examination was unremarkable, apart from some mild pallor. Abnormal chest x-ray findings prompted a computerised tomography (CT) thorax which demonstrated multifocal peri-bronchial consolidation. The differential diagnosis was multifocal organising pneumonia and tuberculosis (TB). Extensive investigations, including invasive bronchial imaging and biopsy, ultimately ruled out TB. This paper reports a case of Adalimumab-induced organising pneumonia and discusses its clinical implications.

一名 26 岁的女性患者因干咳、无意中体重减轻、盗汗和乏力就诊 3 个月。她曾患溃疡性结肠炎,使用阿达木单抗治疗近两年。临床检查无异常,只是有些轻微苍白。异常的胸部X光检查结果促使她接受了胸部计算机断层扫描(CT)检查,结果显示多灶性支气管周围合并症。鉴别诊断为多灶性组织化肺炎和肺结核(TB)。包括侵入性支气管成像和活检在内的广泛检查最终排除了肺结核的可能性。本文报告了一例阿达木单抗诱发的组织性肺炎病例,并讨论了其临床意义。
{"title":"TB or Not TB, That is the Question?","authors":"Ellen McAuliffe, Bryan Renton","doi":"10.12968/hmed.2024.0180","DOIUrl":"https://doi.org/10.12968/hmed.2024.0180","url":null,"abstract":"<p><p>A 26-year-old female presented with a 3-month history of dry cough, unintentional weight loss, night sweats and fatigue. Her background history was significant for ulcerative colitis, managed with Adalimumab for almost 2 years. Clinical examination was unremarkable, apart from some mild pallor. Abnormal chest x-ray findings prompted a computerised tomography (CT) thorax which demonstrated multifocal peri-bronchial consolidation. The differential diagnosis was multifocal organising pneumonia and tuberculosis (TB). Extensive investigations, including invasive bronchial imaging and biopsy, ultimately ruled out TB. This paper reports a case of Adalimumab-induced organising pneumonia and discusses its clinical implications.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"85 10","pages":"1-7"},"PeriodicalIF":1.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Sarcobesity Index and Body Adipose Tissue Variables on Cardiopulmonary Exercise Testing Performance in Colorectal Surgery Setting: A Retrospective Cohort Study. 结直肠手术患者肥胖指数和身体脂肪组织变量对心肺运动测试成绩的影响:一项回顾性队列研究
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 Epub Date: 2024-10-17 DOI: 10.12968/hmed.2024.0373
Emma Kirby, Winnie Tam, Iain Gilham, Adetona Obaloluwa Babs-Osibodu, William Jones, Shahin Hajibandeh, Shahab Hajibandeh, George A Rose, Damian M Bailey, Christopher Morris, Rachel Hargest, Amy Clayton, Richard G Davies

Aims/Background The prognostic significance of body composition variables has become a popular area of research over the recent years. This study aimed to determine whether adipose tissue variables and sarcobesity index measured by computed tomography (CT) could predict cardiopulmonary exercise testing (CPET) performance and long-term mortality in patients undergoing major colorectal surgery. Methods The Strengthening the Reporting of Cohort Studies in Surgery (STROCSS) statement standards were followed to conduct a retrospective cohort study of consecutive patients who had CPET prior to major colorectal surgery between January 2011 and January 2017. Receiver Operating Characteristic curve analysis was conducted to assess the discriminative performances of adipose tissue variables. The association between CT-derived adipose tissue variables (sarcobesity index, visceral adipose tissue, subcutaneous adipose tissue, and total adipose tissue) and CPET performance and mortality were assessed using regression analyses. Results 457 patients were included. Total adipose tissue evaluated via 2-dimensional (2D) and 3-dimensional (3D) approaches predicted oxygen uptake (O2) Rest, O2 anaerobic threshold (AT), ventilatory equivalents for carbon dioxide (E/CO2) AT, ventilatory equivalents for oxygen (E/O2) AT, O2 peak, exercise time, maximum work, peak metabolic equivalents (METS), peak respiratory rate (RER), and peak oxygen pulse. Sarcobesity index (2D and 3D) predicted O2 Rest, O2 AT, E/CO2 AT, O2 peak, maximum work, peak METS, maximum heart rate, and peak RER. Neither total adipose tissue nor sarcobesity index (2D and 3D) predicted 1-year, 3-year, or 5-year mortality. There was no difference in the discriminative performance of adipose tissue variables in predicting mortality. Conclusion The CPET performance may be predicted by radiologically measured adipose tissue variables and sarcobesity index. However, the prognostic value of the variables may not be significant in this setting.

目的/背景 近年来,身体成分变量的预后意义已成为一个热门研究领域。本研究旨在确定通过计算机断层扫描(CT)测量的脂肪组织变量和肌肉肥胖指数能否预测接受大肠直肠手术患者的心肺运动测试(CPET)表现和长期死亡率。方法 按照《加强外科队列研究报告》(STROCSS)声明标准,对 2011 年 1 月至 2017 年 1 月间接受大肠直肠手术前进行 CPET 的连续患者进行回顾性队列研究。为评估脂肪组织变量的鉴别性能,进行了接收者操作特征曲线分析。使用回归分析评估了 CT 衍生的脂肪组织变量(肌肥胖指数、内脏脂肪组织、皮下脂肪组织和总脂肪组织)与 CPET 性能和死亡率之间的关联。结果 共纳入 457 名患者。通过二维(2D)和三维(3D)方法评估的总脂肪组织可预测摄氧量(VÌO2)Rest、VÌO2无氧阈值(AT)、二氧化碳通气当量(VÌE/VÌCO2)AT、氧的通气当量(V.J.E/V.J.O2)AT、V.J.O2 峰值、运动时间、最大功、代谢当量峰值(METS)、呼吸频率峰值(RER)和氧脉搏峰值。肥胖指数(二维和三维)可预测静止时的掺氧量、掺氧量 AT、掺氧量 AT、掺氧量峰值、最大做功、METS 峰值、最大心率和 RER 峰值。总脂肪组织和肌肉肥胖指数(2D和3D)均不能预测1年、3年或5年的死亡率。脂肪组织变量在预测死亡率方面的鉴别性能没有差异。结论 CPET 性能可通过放射学测量的脂肪组织变量和肌肉肥胖指数进行预测。但是,在这种情况下,这些变量的预后价值可能并不显著。
{"title":"Effect of Sarcobesity Index and Body Adipose Tissue Variables on Cardiopulmonary Exercise Testing Performance in Colorectal Surgery Setting: A Retrospective Cohort Study.","authors":"Emma Kirby, Winnie Tam, Iain Gilham, Adetona Obaloluwa Babs-Osibodu, William Jones, Shahin Hajibandeh, Shahab Hajibandeh, George A Rose, Damian M Bailey, Christopher Morris, Rachel Hargest, Amy Clayton, Richard G Davies","doi":"10.12968/hmed.2024.0373","DOIUrl":"https://doi.org/10.12968/hmed.2024.0373","url":null,"abstract":"<p><p><b>Aims/Background</b> The prognostic significance of body composition variables has become a popular area of research over the recent years. This study aimed to determine whether adipose tissue variables and sarcobesity index measured by computed tomography (CT) could predict cardiopulmonary exercise testing (CPET) performance and long-term mortality in patients undergoing major colorectal surgery. <b>Methods</b> The Strengthening the Reporting of Cohort Studies in Surgery (STROCSS) statement standards were followed to conduct a retrospective cohort study of consecutive patients who had CPET prior to major colorectal surgery between January 2011 and January 2017. Receiver Operating Characteristic curve analysis was conducted to assess the discriminative performances of adipose tissue variables. The association between CT-derived adipose tissue variables (sarcobesity index, visceral adipose tissue, subcutaneous adipose tissue, and total adipose tissue) and CPET performance and mortality were assessed using regression analyses. <b>Results</b> 457 patients were included. Total adipose tissue evaluated via 2-dimensional (2D) and 3-dimensional (3D) approaches predicted oxygen uptake (<i>V̇</i>O<sub>2</sub>) Rest, <i>V̇</i>O<sub>2</sub> anaerobic threshold (AT), ventilatory equivalents for carbon dioxide (<i>V̇</i>E/<i>V̇</i>CO<sub>2</sub>) AT, ventilatory equivalents for oxygen (<i>V̇</i>E/<i>V̇</i>O<sub>2</sub>) AT, <i>V̇</i>O<sub>2</sub> peak, exercise time, maximum work, peak metabolic equivalents (METS), peak respiratory rate (RER), and peak oxygen pulse. Sarcobesity index (2D and 3D) predicted <i>V̇</i>O<sub>2</sub> Rest, <i>V̇</i>O<sub>2</sub> AT, <i>V̇</i>E/<i>V̇</i>CO<sub>2</sub> AT, <i>V̇</i>O<sub>2</sub> peak, maximum work, peak METS, maximum heart rate, and peak RER. Neither total adipose tissue nor sarcobesity index (2D and 3D) predicted 1-year, 3-year, or 5-year mortality. There was no difference in the discriminative performance of adipose tissue variables in predicting mortality. <b>Conclusion</b> The CPET performance may be predicted by radiologically measured adipose tissue variables and sarcobesity index. However, the prognostic value of the variables may not be significant in this setting.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"85 10","pages":"1-17"},"PeriodicalIF":1.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive Value of PHRI for Recurrence within One Year after UC Treatment: A Retrospective Study. PHRI 对 UC 治疗后一年内复发的预测价值:一项回顾性研究
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 Epub Date: 2024-10-17 DOI: 10.12968/hmed.2024.0425
Kun Zhang, Jianlan Xie, Jianmin Zhao, Mei Jia
<p><p><b>Aims/Background</b> Accurate prediction of recurrence after treatment is crucial for controlling the progression and improving the prognosis of active ulcerative colitis (UC) patients. Previous studies have evaluated the therapeutic response in UC patients by assessing mucosal healing, using measures such as the Paddington International Virtual ChromoendoScopy Score (PICaSSO) and the PICaSSO Histological Remission Index (PHRI). The PHRI is effective for evaluating treatment response and disease control in UC patients, but its predictive value for short-term recurrence has not been reported in the literature. Therefore, this retrospective analysis of clinical data aims to explore the predictive value of the PHRI and provide a reference for improving the prognosis of UC patients. <b>Methods</b> Clinical data of UC patients in clinical remission admitted to our hospital from June 2017 to June 2023 were retrospectively collected. Patients were divided into the recurrence group and the non-recurrence group, based on whether they experienced recurrence during the one-year follow-up. Clinical data, laboratory test results, and PHRI scores were collected. Variables that showed statistically significant differences between groups in univariate analysis were included in multivariate logistic regression analysis. The predictive value of PHRI was analyzed with receiver operating characteristic (ROC) curve analysis. <b>Results</b> One hundred and two UC patients in the clinical remission stage were included in this study, and there were no cases of loss to follow-up. Among them, 36 patients (35.29%) experienced recurrence within the one-year follow-up, whereas 66 patients (64.71%) did not. Compared with the non-recurrence group, the recurrence group had a more number of cases with lesions in the left-sided colon and extensive colon, higher percentages of cases that were moderate or severe, and a significantly higher colonoscopy score (<i>p</i> < 0.05). Compared with the non-recurrence group, the PHRI score of the recurrence group was significantly higher (<i>p</i> < 0.001). Multivariate logistic regression analysis showed that that the lesion range (OR = 4.127, <i>p</i> = 0.005), disease severity (OR = 3.889, <i>p</i> = 0.019), colonoscopy score (OR = 6.128, <i>p</i> < 0.001), and PHRI score (OR = 5.466, <i>p</i> < 0.001) were independent risk factors for recurrence in UC patients. The results of ROC curve analysis showed that the area under the curve of the PHRI score in predicting the recurrence of UC patients was 0.838 (95% CI: 0.760-0.916). When the optimal cut-off value was 1 point, the sensitivity and specificity were the highest, which were 89.58% and 65.58%, respectively, indicating that PHRI score had good predictive value. <b>Conclusion</b> The lesion extent, disease severity, endoscopic score, and PHRI score are associated with recurrence within one year in UC patients in the clinical remission stage, and the PHRI score has good predictive
目的/背景 准确预测治疗后的复发对于控制病情发展和改善活动性溃疡性结肠炎(UC)患者的预后至关重要。以往的研究通过评估粘膜愈合情况来评估 UC 患者的治疗反应,采用的方法包括帕丁顿国际虚拟 ChromoendoScopy 评分(PICaSSO)和 PICaSSO 组织学缓解指数(PHRI)。PHRI 可有效评估 UC 患者的治疗反应和疾病控制情况,但其对短期复发的预测价值尚未见文献报道。因此,本研究对临床数据进行回顾性分析,旨在探讨 PHRI 的预测价值,为改善 UC 患者的预后提供参考。方法 回顾性收集2017年6月至2023年6月我院收治的临床缓解期UC患者的临床资料。根据一年随访期间是否复发,将患者分为复发组和未复发组。收集了临床数据、实验室检查结果和 PHRI 评分。单变量分析显示组间存在显著统计学差异的变量被纳入多变量逻辑回归分析。PHRI的预测价值通过接收者操作特征曲线(ROC)分析得出。结果 本研究共纳入了 122 例处于临床缓解期的 UC 患者,无一例失访。其中,36 名患者(35.29%)在一年随访期内复发,66 名患者(64.71%)未复发。与未复发组相比,复发组病变位于左侧结肠和广泛结肠的病例数更多,中度或重度病例的比例更高,结肠镜评分也明显更高(P < 0.05)。与未复发组相比,复发组的 PHRI 评分明显更高(P < 0.001)。多变量逻辑回归分析显示,病变范围(OR = 4.127,p = 0.005)、疾病严重程度(OR = 3.889,p = 0.019)、结肠镜评分(OR = 6.128,p < 0.001)和 PHRI 评分(OR = 5.466,p < 0.001)是 UC 患者复发的独立危险因素。ROC曲线分析结果显示,PHRI评分预测UC患者复发的曲线下面积为0.838(95% CI:0.760-0.916)。当最佳临界值为 1 分时,敏感性和特异性最高,分别为 89.58% 和 65.58%,表明 PHRI 评分具有良好的预测价值。结论 病变范围、疾病严重程度、内镜评分和 PHRI 评分与临床缓解期 UC 患者一年内的复发有关,PHRI 评分具有良好的预测价值。
{"title":"Predictive Value of PHRI for Recurrence within One Year after UC Treatment: A Retrospective Study.","authors":"Kun Zhang, Jianlan Xie, Jianmin Zhao, Mei Jia","doi":"10.12968/hmed.2024.0425","DOIUrl":"https://doi.org/10.12968/hmed.2024.0425","url":null,"abstract":"&lt;p&gt;&lt;p&gt;&lt;b&gt;Aims/Background&lt;/b&gt; Accurate prediction of recurrence after treatment is crucial for controlling the progression and improving the prognosis of active ulcerative colitis (UC) patients. Previous studies have evaluated the therapeutic response in UC patients by assessing mucosal healing, using measures such as the Paddington International Virtual ChromoendoScopy Score (PICaSSO) and the PICaSSO Histological Remission Index (PHRI). The PHRI is effective for evaluating treatment response and disease control in UC patients, but its predictive value for short-term recurrence has not been reported in the literature. Therefore, this retrospective analysis of clinical data aims to explore the predictive value of the PHRI and provide a reference for improving the prognosis of UC patients. &lt;b&gt;Methods&lt;/b&gt; Clinical data of UC patients in clinical remission admitted to our hospital from June 2017 to June 2023 were retrospectively collected. Patients were divided into the recurrence group and the non-recurrence group, based on whether they experienced recurrence during the one-year follow-up. Clinical data, laboratory test results, and PHRI scores were collected. Variables that showed statistically significant differences between groups in univariate analysis were included in multivariate logistic regression analysis. The predictive value of PHRI was analyzed with receiver operating characteristic (ROC) curve analysis. &lt;b&gt;Results&lt;/b&gt; One hundred and two UC patients in the clinical remission stage were included in this study, and there were no cases of loss to follow-up. Among them, 36 patients (35.29%) experienced recurrence within the one-year follow-up, whereas 66 patients (64.71%) did not. Compared with the non-recurrence group, the recurrence group had a more number of cases with lesions in the left-sided colon and extensive colon, higher percentages of cases that were moderate or severe, and a significantly higher colonoscopy score (&lt;i&gt;p&lt;/i&gt; &lt; 0.05). Compared with the non-recurrence group, the PHRI score of the recurrence group was significantly higher (&lt;i&gt;p&lt;/i&gt; &lt; 0.001). Multivariate logistic regression analysis showed that that the lesion range (OR = 4.127, &lt;i&gt;p&lt;/i&gt; = 0.005), disease severity (OR = 3.889, &lt;i&gt;p&lt;/i&gt; = 0.019), colonoscopy score (OR = 6.128, &lt;i&gt;p&lt;/i&gt; &lt; 0.001), and PHRI score (OR = 5.466, &lt;i&gt;p&lt;/i&gt; &lt; 0.001) were independent risk factors for recurrence in UC patients. The results of ROC curve analysis showed that the area under the curve of the PHRI score in predicting the recurrence of UC patients was 0.838 (95% CI: 0.760-0.916). When the optimal cut-off value was 1 point, the sensitivity and specificity were the highest, which were 89.58% and 65.58%, respectively, indicating that PHRI score had good predictive value. &lt;b&gt;Conclusion&lt;/b&gt; The lesion extent, disease severity, endoscopic score, and PHRI score are associated with recurrence within one year in UC patients in the clinical remission stage, and the PHRI score has good predictive","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"85 10","pages":"1-11"},"PeriodicalIF":1.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perioperative Point-of-Care Ultrasound (POCUS) for Anaesthetists: Is It Time to Introduce Formal Training? 麻醉师围术期护理点超声 (POCUS):现在是引入正式培训的时候了吗?
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 Epub Date: 2024-10-27 DOI: 10.12968/hmed.2024.0398
Luke Wynne

This article reviews point-of-care ultrasound (POCUS) in the perioperative period. Ultrasound-guided techniques for regional anaesthesia and vascular access have been well-established in anaesthesia for many years. However, integration of whole-body POCUS into UK anaesthetic practice remains limited. There is a growing body of evidence highlighting the benefits of POCUS throughout the perioperative period. Widespread use may help to improve patient care in anaesthesia.

本文回顾了围手术期的护理点超声(POCUS)。多年来,用于区域麻醉和血管通路的超声引导技术已在麻醉领域得到广泛应用。然而,全身 POCUS 在英国麻醉实践中的应用仍然有限。越来越多的证据表明,POCUS 在整个围手术期都有诸多益处。广泛使用 POCUS 有助于改善麻醉中的患者护理。
{"title":"Perioperative Point-of-Care Ultrasound (POCUS) for Anaesthetists: Is It Time to Introduce Formal Training?","authors":"Luke Wynne","doi":"10.12968/hmed.2024.0398","DOIUrl":"https://doi.org/10.12968/hmed.2024.0398","url":null,"abstract":"<p><p>This article reviews point-of-care ultrasound (POCUS) in the perioperative period. Ultrasound-guided techniques for regional anaesthesia and vascular access have been well-established in anaesthesia for many years. However, integration of whole-body POCUS into UK anaesthetic practice remains limited. There is a growing body of evidence highlighting the benefits of POCUS throughout the perioperative period. Widespread use may help to improve patient care in anaesthesia.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"85 10","pages":"1-3"},"PeriodicalIF":1.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ganglioglioma with MAP2K1 Mutation and CDKN2A/B Homozygous Deletion: A Case Report. 伴有 MAP2K1 突变和 CDKN2A/B 基因同源缺失的神经节胶质瘤:病例报告
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 Epub Date: 2024-10-14 DOI: 10.12968/hmed.2024.0379
Chi Zhao, Cheng Li, Jing-Jing Ge, Jun-Ping Zhang

Aims/Background Gangliogliomas are grade 1 glioneuronal tumors occurring predominantly in the temporal lobe, as per the World Health Organization (WHO) classification. Gangliogliomas often harbor BRAF (v-Raf murine sarcoma viral oncogene homolog B1) p.V600E hotspot mutation or other alterations leading to activation of RAS/RAF/MAPK (rat sarcoma virus oncogene/rapidly accelerated fibrosarcoma/mitogen-activated protein kinase) signaling pathway, which is the driver factor of this tumor. This study aims to investigate a case of ganglioglioma patient with distinctive molecular features, and to present the clinical and pathological characteristics as well as the treatment employed for this individual. Case Presentation We reported a primary ganglioglioma harboring MAP2K1 (mitogen-activated protein kinase kinase 1) mutation and CDKN2A/B (cyclin-dependent kinase inhibitor 2A/2B) homozygous deletion in a 4-year-old patient. The patient experienced tumor recurrence 12 months after gross total resection of the tumor. Subsequently, salvage chemotherapy with a combination of temozolomide and irinotecan was administered, resulting in effective control of the tumor. Conclusion To our knowledge, this is the first reported case of ganglioglioma with anaplastic features harboring MAP2K1 mutation and homozygous deletion of CDKN2A/B. These findings may shed light on the genetic features of ganglioglioma and offers insights into potential therapeutic approaches for this rare neoplasm.

目的/背景 根据世界卫生组织(WHO)的分类,神经胶质细胞瘤是主要发生在颞叶的1级神经胶质细胞瘤。神经节胶质瘤通常携带 BRAF(v-Raf 小鼠肉瘤病毒癌基因同源物 B1)p.V600E 热点突变或其他改变,导致 RAS/RAF/MAPK(大鼠肉瘤病毒癌基因/快速加速纤维肉瘤/介原激活蛋白激酶)信号通路激活,而这正是这种肿瘤的驱动因素。本研究旨在探讨一例具有独特分子特征的神经节胶质瘤患者,并介绍其临床和病理特征以及治疗方法。病例介绍 我们报告了一名 4 岁患者的原发性神经节胶质瘤,该患者携带 MAP2K1(丝裂原活化蛋白激酶激酶 1)突变和 CDKN2A/B(细胞周期蛋白依赖性激酶抑制剂 2A/2B)同基因缺失。患者在肿瘤全切12个月后出现肿瘤复发。随后,患者接受了替莫唑胺和伊立替康的联合挽救性化疗,肿瘤得到了有效控制。结论 据我们所知,这是首例报道的神经节胶质瘤,具有无弹性特征,且携带 MAP2K1 突变和 CDKN2A/B 基因同源缺失。这些发现可能揭示了神经节胶质瘤的遗传特征,并为这种罕见肿瘤的潜在治疗方法提供了启示。
{"title":"Ganglioglioma with <i>MAP2K1</i> Mutation and <i>CDKN2A/B</i> Homozygous Deletion: A Case Report.","authors":"Chi Zhao, Cheng Li, Jing-Jing Ge, Jun-Ping Zhang","doi":"10.12968/hmed.2024.0379","DOIUrl":"https://doi.org/10.12968/hmed.2024.0379","url":null,"abstract":"<p><p><b>Aims/Background</b> Gangliogliomas are grade 1 glioneuronal tumors occurring predominantly in the temporal lobe, as per the World Health Organization (WHO) classification. Gangliogliomas often harbor <i>BRAF</i> (v-Raf murine sarcoma viral oncogene homolog B1) p.V600E hotspot mutation or other alterations leading to activation of RAS/RAF/MAPK (rat sarcoma virus oncogene/rapidly accelerated fibrosarcoma/mitogen-activated protein kinase) signaling pathway, which is the driver factor of this tumor. This study aims to investigate a case of ganglioglioma patient with distinctive molecular features, and to present the clinical and pathological characteristics as well as the treatment employed for this individual. <b>Case Presentation</b> We reported a primary ganglioglioma harboring <i>MAP2K1</i> (mitogen-activated protein kinase kinase 1) mutation and <i>CDKN2A/B</i> (cyclin-dependent kinase inhibitor 2A/2B) homozygous deletion in a 4-year-old patient. The patient experienced tumor recurrence 12 months after gross total resection of the tumor. Subsequently, salvage chemotherapy with a combination of temozolomide and irinotecan was administered, resulting in effective control of the tumor. <b>Conclusion</b> To our knowledge, this is the first reported case of ganglioglioma with anaplastic features harboring <i>MAP2K1</i> mutation and homozygous deletion of <i>CDKN2A/B</i>. These findings may shed light on the genetic features of ganglioglioma and offers insights into potential therapeutic approaches for this rare neoplasm.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"85 10","pages":"1-10"},"PeriodicalIF":1.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and Validation of a Nomogram Prediction Model for Moderate-to-Severe Acute Radiation Dermatitis in Patients with Breast Cancer: A Retrospective Study. 乳腺癌患者中度至重度急性放射性皮炎提名图预测模型的开发与验证:一项回顾性研究
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 Epub Date: 2024-10-14 DOI: 10.12968/hmed.2024.0254
Na Cui, Jia Wu, Xinchun Zhang, Yingna Pu, Bei Zhao, Tingting Han, Ling Chen

Aims/Background Acute radiation dermatitis is the most common complication of radiotherapy in patients with breast cancer, with mild severity relieved by symptomatic treatment and moderate-to-severe severity leading to compromised skin integrity and affecting the patient's quality of life. Therefore, this study aims to develop a prediction model for moderate-to-severe acute radiation dermatitis in patients with breast cancer to reduce its severity. Methods A retrospective analysis of 713 patients receiving radiotherapy for breast cancer at the Affiliated Cancer Hospital of Xinjiang Medical University from January 2019 to December 2023 was conducted, with January 2019 to December 2021 serving as the training group (497 patients) and January 2022 to December 2023 serving as the validation group (216 patients). Patients in the training group were classified as having mild (383 patients) or moderately severe (114 patients) acute radiation dermatitis. Binary logistic regression was used to analyze the independent effects on moderately severe acute radiation dermatitis in patients with breast cancer, and a predictive model of the bar-folding plot was constructed and validated. Results Univariable analysis revealed that age, body mass index, targeted therapy, oral tamoxifen use, hyperlipidemia, diabetes, positive regional lymph node metastasis, value-added index, and triple-negative breast cancer were factors influencing moderate-to-severe acute radiation dermatitis in patients with breast cancer. Multivariate analysis showed that body mass index, hyperlipidemia, diabetes, positive regional lymph node metastasis, and value-added index were independent influencing factors for moderate-to-severe acute radiation dermatitis in patients with breast cancer. A nomogram prediction model was constructed, and the area under the receiver operating characteristic curve of the model was 0.814 and 0.743 for internal and external validation, respectively. The calibration curve showed that the model predicted moderate-to-severe acute radiation dermatitis better, and the decision curve analysis curve showed that the model had a high clinical benefit. Conclusion This risk prediction model can predict moderate-to-severe acute radiation dermatitis in patients with breast cancer, and help clinical providers screen high-risk patients and reduce acute radiation dermatitis severity.

目的/背景 急性放射性皮炎是乳腺癌患者接受放疗后最常见的并发症,轻度时可通过对症治疗缓解,中重度时会导致皮肤完整性受损,影响患者的生活质量。因此,本研究旨在建立乳腺癌患者中重度急性放射性皮炎的预测模型,以降低其严重程度。方法 对2019年1月至2023年12月在新疆医科大学附属肿瘤医院接受乳腺癌放疗的713名患者进行回顾性分析,其中2019年1月至2021年12月为训练组(497名患者),2022年1月至2023年12月为验证组(216名患者)。训练组患者被分为轻度(383 例)或中度(114 例)急性放射性皮炎患者。采用二元逻辑回归分析了中度严重急性放射性皮炎对乳腺癌患者的独立影响,并构建和验证了条形折叠图预测模型。结果 单变量分析显示,年龄、体重指数、靶向治疗、口服他莫昔芬、高脂血症、糖尿病、区域淋巴结转移阳性、增值指数和三阴性乳腺癌是影响乳腺癌患者中重度急性放射性皮炎的因素。多变量分析表明,体重指数、高脂血症、糖尿病、区域淋巴结转移阳性和增值指数是乳腺癌患者中重度急性放射性皮炎的独立影响因素。构建了一个提名图预测模型,内部和外部验证的模型接收者操作特征曲线下面积分别为 0.814 和 0.743。校准曲线显示,该模型能较好地预测中重度急性放射性皮炎,决策曲线分析曲线显示,该模型具有较高的临床效益。结论 该风险预测模型可预测乳腺癌患者的中重度急性放射性皮炎,有助于临床医生筛查高危患者,降低急性放射性皮炎的严重程度。
{"title":"Development and Validation of a Nomogram Prediction Model for Moderate-to-Severe Acute Radiation Dermatitis in Patients with Breast Cancer: A Retrospective Study.","authors":"Na Cui, Jia Wu, Xinchun Zhang, Yingna Pu, Bei Zhao, Tingting Han, Ling Chen","doi":"10.12968/hmed.2024.0254","DOIUrl":"https://doi.org/10.12968/hmed.2024.0254","url":null,"abstract":"<p><p><b>Aims/Background</b> Acute radiation dermatitis is the most common complication of radiotherapy in patients with breast cancer, with mild severity relieved by symptomatic treatment and moderate-to-severe severity leading to compromised skin integrity and affecting the patient's quality of life. Therefore, this study aims to develop a prediction model for moderate-to-severe acute radiation dermatitis in patients with breast cancer to reduce its severity. <b>Methods</b> A retrospective analysis of 713 patients receiving radiotherapy for breast cancer at the Affiliated Cancer Hospital of Xinjiang Medical University from January 2019 to December 2023 was conducted, with January 2019 to December 2021 serving as the training group (497 patients) and January 2022 to December 2023 serving as the validation group (216 patients). Patients in the training group were classified as having mild (383 patients) or moderately severe (114 patients) acute radiation dermatitis. Binary logistic regression was used to analyze the independent effects on moderately severe acute radiation dermatitis in patients with breast cancer, and a predictive model of the bar-folding plot was constructed and validated. <b>Results</b> Univariable analysis revealed that age, body mass index, targeted therapy, oral tamoxifen use, hyperlipidemia, diabetes, positive regional lymph node metastasis, value-added index, and triple-negative breast cancer were factors influencing moderate-to-severe acute radiation dermatitis in patients with breast cancer. Multivariate analysis showed that body mass index, hyperlipidemia, diabetes, positive regional lymph node metastasis, and value-added index were independent influencing factors for moderate-to-severe acute radiation dermatitis in patients with breast cancer. A nomogram prediction model was constructed, and the area under the receiver operating characteristic curve of the model was 0.814 and 0.743 for internal and external validation, respectively. The calibration curve showed that the model predicted moderate-to-severe acute radiation dermatitis better, and the decision curve analysis curve showed that the model had a high clinical benefit. <b>Conclusion</b> This risk prediction model can predict moderate-to-severe acute radiation dermatitis in patients with breast cancer, and help clinical providers screen high-risk patients and reduce acute radiation dermatitis severity.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"85 10","pages":"1-18"},"PeriodicalIF":1.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ring-Enhancing Lesions-Differentiation with MRI. 环状强化病变--通过核磁共振成像进行鉴别。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 Epub Date: 2024-10-29 DOI: 10.12968/hmed.2024.0195
Elif Peker, Sena Ünal, Sena Bozer Uludağ, Nil Sezer Yılmazer Zorlu

Lesions with central hypointensity and peripheral contrast enhancement are defined as ring-enhancing lesions. The aetiologies of ring-enhancing lesions may be various, including infections, tumours, demyelinating diseases, treatment-related conditions and hematoma. The imaging findings and their distinguishing features also vary among different ring-enhancing lesions. This review examines the magnetic resonance imaging findings of different ring-enhancing lesions and their distinguishing features.

中心低密度和周边对比度增强的病变被定义为环形增强病变。环形强化病变的病因多种多样,包括感染、肿瘤、脱髓鞘疾病、治疗相关疾病和血肿。不同的环形强化病变的成像结果及其鉴别特征也各不相同。本综述探讨了不同环形增强病变的磁共振成像结果及其区别特征。
{"title":"Ring-Enhancing Lesions-Differentiation with MRI.","authors":"Elif Peker, Sena Ünal, Sena Bozer Uludağ, Nil Sezer Yılmazer Zorlu","doi":"10.12968/hmed.2024.0195","DOIUrl":"https://doi.org/10.12968/hmed.2024.0195","url":null,"abstract":"<p><p>Lesions with central hypointensity and peripheral contrast enhancement are defined as ring-enhancing lesions. The aetiologies of ring-enhancing lesions may be various, including infections, tumours, demyelinating diseases, treatment-related conditions and hematoma. The imaging findings and their distinguishing features also vary among different ring-enhancing lesions. This review examines the magnetic resonance imaging findings of different ring-enhancing lesions and their distinguishing features.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"85 10","pages":"1-20"},"PeriodicalIF":1.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Discrimination Model Construction for Non-Lactational Mastitis and Breast Cancer Based on Imaging Features. 基于成像特征构建非哺乳期乳腺炎和乳腺癌的鉴别模型
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-10-30 Epub Date: 2024-10-29 DOI: 10.12968/hmed.2024.0278
Jinjuan Peng, Meng Zhao, Shui Wang

Aims/Background The clinical presentation of non-lactational mastitis (NLM) shares similarities with some symptoms and examination results of breast cancer (BC), which can lead to misdiagnosis or delayed treatment. Current studies on breast lesions mostly focus on the diagnostic performance of a single imaging technique. This study aims to construct a discrimination diagnostic model for NLM and BC based on such imaging features as ultrasound and magnetic resonance imaging (MRI) and to validate the application value of the model, assisting clinicians in improving disease diagnosis and refining medical decisions. Methods This study is a retrospective analysis. Clinical data of 108 patients suspected of NLM based on imaging diagnosis, admitted to The First Affiliated Hospital with Nanjing Medical University between May 2018 and August 2023, were collected. Among them, 94 cases were pathologically confirmed as NLM and 14 cases as BC. Univariate and multivariate logistic regression analyses were performed on the patients' clinical data, ultrasound features, and MRI features to select the risk factors for discriminating NLM and BC, and construct a discrimination model. The discrimination performance of the model was analyzed with the receiver operating characteristic (ROC) curve, decision curve analysis (DCA), and calibration curve. Results In the NLM group, there were 24 cases of granulomatous lobular mastitis (25.53%) and 70 cases of plasma cell mastitis (74.47%). In the BC group, there were 2 cases of infiltrating ductal carcinoma, 2 cases of atypical hyperplasia, 3 cases of papillary carcinoma, and 7 cases of ductal carcinoma in situ. Age, internal blood flow, calcification, edge, enhancement characteristics, apparent diffusion coefficient (ADC) values, and time-intensity curve (TIC) type were independent factors for differentiating NLM and BC (p < 0.05). The ROC analysis showed that the area under the curve of the model for discriminating NLM and BC was 0.920. The DCA results showed that the model had high net benefits for discriminating NLM and BC. The calibration curve analysis showed that the model had good consistency with the actual diagnosis of NLM and BC, with a chi-square value of 4.545 and a p-value of 0.155 according to the Hosmer-Lemeshow test. Conclusion Age, internal blood flow, calcification, edge, enhancement characteristics, ADC, and TIC curve types are important factors in distinguishing NLM and BC, and the model based on the above characteristics to distinguish NLM and BC has a high net benefit in distinguishing the two.

目的/背景 非哺乳期乳腺炎(NLM)的临床表现与乳腺癌(BC)的某些症状和检查结果相似,可能导致误诊或延误治疗。目前有关乳腺病变的研究大多集中在单一成像技术的诊断性能上。本研究旨在基于超声和核磁共振成像(MRI)等影像学特征,构建NLM和BC的鉴别诊断模型,并验证该模型的应用价值,帮助临床医生改进疾病诊断和完善医疗决策。方法 本研究为回顾性分析。收集了南京医科大学第一附属医院于2018年5月至2023年8月期间收治的108例根据影像学诊断疑似南京脑瘤患者的临床资料。其中,94例经病理证实为NLM,14例为BC。对患者的临床数据、超声特征和磁共振成像特征进行单变量和多变量逻辑回归分析,筛选出鉴别NLM和BC的风险因素,并构建了鉴别模型。用接收者操作特征曲线(ROC)、决策曲线分析(DCA)和校准曲线分析模型的判别性能。结果 在 NLM 组中,肉芽肿性小叶性乳腺炎 24 例(25.53%),浆细胞性乳腺炎 70 例(74.47%)。在 BC 组中,有 2 例浸润性导管癌、2 例不典型增生、3 例乳头状癌和 7 例导管原位癌。年龄、内部血流、钙化、边缘、增强特征、表观弥散系数(ADC)值和时间-强度曲线(TIC)类型是区分 NLM 和 BC 的独立因素(P < 0.05)。ROC 分析显示,区分 NLM 和 BC 的模型曲线下面积为 0.920。DCA 结果显示,该模型在区分 NLM 和 BC 方面具有较高的净效益。校准曲线分析表明,该模型与 NLM 和 BC 的实际诊断具有良好的一致性,根据 Hosmer-Lemeshow 检验,该模型的卡方值为 4.545,P 值为 0.155。结论 年龄、内部血流、钙化、边缘、增强特征、ADC 和 TIC 曲线类型是区分 NLM 和 BC 的重要因素,基于上述特征的模型在区分 NLM 和 BC 方面具有较高的净效益。
{"title":"Discrimination Model Construction for Non-Lactational Mastitis and Breast Cancer Based on Imaging Features.","authors":"Jinjuan Peng, Meng Zhao, Shui Wang","doi":"10.12968/hmed.2024.0278","DOIUrl":"https://doi.org/10.12968/hmed.2024.0278","url":null,"abstract":"<p><p><b>Aims/Background</b> The clinical presentation of non-lactational mastitis (NLM) shares similarities with some symptoms and examination results of breast cancer (BC), which can lead to misdiagnosis or delayed treatment. Current studies on breast lesions mostly focus on the diagnostic performance of a single imaging technique. This study aims to construct a discrimination diagnostic model for NLM and BC based on such imaging features as ultrasound and magnetic resonance imaging (MRI) and to validate the application value of the model, assisting clinicians in improving disease diagnosis and refining medical decisions. <b>Methods</b> This study is a retrospective analysis. Clinical data of 108 patients suspected of NLM based on imaging diagnosis, admitted to The First Affiliated Hospital with Nanjing Medical University between May 2018 and August 2023, were collected. Among them, 94 cases were pathologically confirmed as NLM and 14 cases as BC. Univariate and multivariate logistic regression analyses were performed on the patients' clinical data, ultrasound features, and MRI features to select the risk factors for discriminating NLM and BC, and construct a discrimination model. The discrimination performance of the model was analyzed with the receiver operating characteristic (ROC) curve, decision curve analysis (DCA), and calibration curve. <b>Results</b> In the NLM group, there were 24 cases of granulomatous lobular mastitis (25.53%) and 70 cases of plasma cell mastitis (74.47%). In the BC group, there were 2 cases of infiltrating ductal carcinoma, 2 cases of atypical hyperplasia, 3 cases of papillary carcinoma, and 7 cases of ductal carcinoma <i>in situ</i>. Age, internal blood flow, calcification, edge, enhancement characteristics, apparent diffusion coefficient (ADC) values, and time-intensity curve (TIC) type were independent factors for differentiating NLM and BC (<i>p</i> < 0.05). The ROC analysis showed that the area under the curve of the model for discriminating NLM and BC was 0.920. The DCA results showed that the model had high net benefits for discriminating NLM and BC. The calibration curve analysis showed that the model had good consistency with the actual diagnosis of NLM and BC, with a chi-square value of 4.545 and a <i>p</i>-value of 0.155 according to the Hosmer-Lemeshow test. <b>Conclusion</b> Age, internal blood flow, calcification, edge, enhancement characteristics, ADC, and TIC curve types are important factors in distinguishing NLM and BC, and the model based on the above characteristics to distinguish NLM and BC has a high net benefit in distinguishing the two.</p>","PeriodicalId":9256,"journal":{"name":"British journal of hospital medicine","volume":"85 10","pages":"1-15"},"PeriodicalIF":1.0,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142543832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
British journal of hospital medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1